Benzinga's Top Downgrades
Analysts at Goldman Sachs downgraded LinkedIn Corp (NYSE: LNKD) from Buy to Neutral. The target price for LinkedIn has been raised from $162 to $203. LinkedIn shares rose 0.03 percent to $192.26 in pre-market trading.
Raymond James downgraded Alaska Air Group, Inc. (NYSE: ALK) from Strong Buy to Outperform. Alaska Air shares dropped 3.93 percent to close at $64.29 on Monday.
Analysts at RBC Capital downgraded Marinus Pharmaceuticals Inc (NASDAQ: MRNS) from Outperform to Sector Perform. Marinus Pharmaceuticals shares rose 0.652 percent to $1.63 in pre-market trading.
Analysts at Jefferies downgraded LinkedIn Corp (NYSE: LNKD) from Buy to Hold. LinkedIn shares rose 0.03 percent to $192.26 in pre-market trading.
Wells Fargo downgraded Hyatt Hotels Corporation (NYSE: H) from Outperform to Market Perform. Hyatt Hotels shares declined 1.54 percent to close at $46.77 on Monday.
Analysts at Stifel Nicolaus downgraded Navistar International Corp (NYSE: NAV) from Hold to Sell. Navistar shares declined 4.03 percent to $12.63 in pre-market trading.
Deutsche Bank downgraded Gulfport Energy Corporation (NASDAQ: GPOR) from Buy to Hold. Gulfport Energy shares dropped 1.74 percent to close at $32.12 on Monday.
Brean Capital downgraded Revance Therapeutics Inc (NASDAQ: RVNC) from Buy to Hold. Revance Therapeutics shares dipped 23.54 percent to $14.03 in pre-market trading.
Piper Jaffray downgraded LinkedIn Corp (NYSE: LNKD) from Buy to Neutral. LinkedIn shares rose 0.03 percent to $192.26 in pre-market trading.
Latest Ratings for MRNS
|Jun 2016||RBC Capital||Downgrades||Outperform||Sector Perform|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.